Keyword Analysis & Research: asxl1 mds

nature.com

https://www.nature.com/articles/leu2017318

WEBDec 3, 2015 · In myelodysplastic syndromes (MDS), mutations of TP53, EZH2, ETV6, RUNX1 and ASXL1 were shown in a multivariate model to predict for inferior survival … Author: David Sallman, Eric Padron, Christine Vaupel, Thomas Cluzeau, Najla H. Al Ali, Jeffrey E Lancet, Jef... Publish Year: 2015

Author: David Sallman, Eric Padron, Christine Vaupel, Thomas Cluzeau, Najla H. Al Ali, Jeffrey E Lancet, Jef...

Publish Year: 2015

DA: 8 PA: 57 MOZ Rank: 85

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364143/

WEBAsxl1 loss in mice results in MDS that could transform to myeloid leukemia with age, suggesting that Asxl1 deficiency cooperates with additional mutations to induce myeloid … DOI: 10.1016/j.exphem.2022.09.003 Published: 2022/11

DOI: 10.1016/j.exphem.2022.09.003

Published: 2022/11

DA: 91 PA: 26 MOZ Rank: 52

ashpublications.org

https://ashpublications.org/blood/article/131/3/274/38319/ASXL1-mutations-gain-a-function

WEBJan 18, 2018 · Mutations of ASXL1 have been identified in a variety of myeloid neoplasms, including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), … Author: Toshio Kitamura Publish Year: 2018

Author: Toshio Kitamura

Publish Year: 2018

DA: 65 PA: 23 MOZ Rank: 38

ascopubs.org

https://ascopubs.org/doi/10.1200/JCO.2010.33.4938

WEBMay 16, 2011 · Mutations in ASXL1 occurred with a frequency of 20.7% in MDS (n = 40 of 193) with 70% (n = 28) of mutations being frameshift mutations and 30% (n = 12) being … Author: Felicitas Thol, Inna Friesen, Frederik Damm, Haiyang Yun, Eva M. Weissinger, Jürgen Krauter, Kathari... Publish Year: 2011

Author: Felicitas Thol, Inna Friesen, Frederik Damm, Haiyang Yun, Eva M. Weissinger, Jürgen Krauter, Kathari...

Publish Year: 2011

DA: 94 PA: 72 MOZ Rank: 30

biomedcentral.com

https://jhoonline.biomedcentral.com/articles/10.1186/1756-8722-5-12

WEBMar 21, 2012 · ASXL1 mutations are found in myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and … Author: Véronique Gelsi-Boyer, Mandy Brecqueville, Mandy Brecqueville, Raynier Devillier, Raynier Devillier,... Publish Year: 2012

Author: Véronique Gelsi-Boyer, Mandy Brecqueville, Mandy Brecqueville, Raynier Devillier, Raynier Devillier,...

Publish Year: 2012

DA: 67 PA: 75 MOZ Rank: 94

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10807681/

WEBDec 26, 2023 · Our study indicated that mutations in G646W or RUNX1 co‐mutations are closely associated with a dismal clinical outcome in patients with AML and MDS …

DA: 16 PA: 52 MOZ Rank: 83

nih.gov

https://pubmed.ncbi.nlm.nih.gov/27077763/

WEBConclusion: ASXL1 mutations were associated with poor prognosis in MDS, which may contribute to risk stratification and prognostic assessment in the disease. Keywords: …

DA: 57 PA: 98 MOZ Rank: 72

nature.com

https://www.nature.com/articles/bcj201374

WEBJan 17, 2014 · Recently, mutations of the additional sex comb-like 1 ( ASXL1) gene were identified in patients with myelodysplastic syndrome (MDS), but the interaction of this mutation with other genetic...

DA: 7 PA: 27 MOZ Rank: 1

ajmc.com

https://www.ajmc.com/view/asxl1-mutations-associated-with-worse-prognosis-in-mds-and-aml

WEBDecember 18, 2022. Rose McNulty. Article. A recent meta-analysis found ASXL1 mutations to be independent risk factors for worse overall survival and transformation to acute myeloid leukemia...

DA: 95 PA: 83 MOZ Rank: 74

nature.com

https://www.nature.com/articles/s41408-022-00744-z

WEBNov 4, 2022 · For 1 L treatment, patients who received 1 L HMA/Venetoclax were more likely to be categorized as MDS-EB2 based on WHO 2016 classification and more likely …

DA: 63 PA: 15 MOZ Rank: 53